Clinical Labs Asset Sale Agreement with Labcorp (Details) - USD ($) $ in Millions |
2 Months Ended | 9 Months Ended |
---|---|---|
Apr. 16, 2023 |
Apr. 30, 2023 |
|
Clinical Labs Asset Sale Agreement With Labcorp [Abstract] | ||
Cash | $ 146 | |
Termination fee | $ 5 | |
Reimbursement of buyer’s expenses | $ 5 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A payment from an investee, in which the investment basis has previously been reduced to zero. This amount reduces net cash used in operating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase from purchase of security purchased under agreement to resell. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|